A DRUG INTERACTION STUDY EVALUATING THE COADMINISTRATION OF GS-9450, A NOVEL CASPASE INHIBITOR, AND THE FIXED-DOSE COMBINATION OF EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE IN HEALTHY VOLUNTEERS

被引：0
|
作者：
Cornpropst, M. T. [1 ]
Liang, W. [2 ]
Yuen, G. J. [1 ]
Eade, D. [1 ]
Hui, J. [3 ]
Hirsch, K. R. [4 ]
Findlay, J. W. [1 ]
机构：
[1] Gilead Sci Inc, Clin Pharmacol, Durham, NC USA
[2] Gilead Sci Inc, Biometr, Durham, NC USA
[3] Gilead Sci Inc, Bioanalyt, Durham, NC USA
[4] Gilead Sci Inc, Clin Res, Durham, NC USA
来源：
JOURNAL OF HEPATOLOGY | 2010年 / 52卷
关键词：
D O I：
10.1016/S0168-8278(10)60747-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S290 / S290
页数：1
相关论文
共 15 条
  • [1] Efavirenz/emtricitabine/tenofovir disoproxil fumarate fixed-dose combination: first-line therapy for all?
    Goicoechea, Miguel
    Best, Brookie
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (03) : 371 - 382
  • [2] Pharmacokinetics of fixed-dose combination of tenofovir disoproxil fumarate, lamivudine, and efavirenz: results of a randomized, crossover, bioequivalence study
    Abhyankar, Dhiraj
    Shedage, Ashish
    Gole, Milind
    Raut, Preeti
    INTERNATIONAL JOURNAL OF STD & AIDS, 2017, 28 (05) : 491 - 498
  • [3] Pharmacokinetic Interactions Between the Fixed-Dose Combinations of Elvitegravir/Cobicistat/Tenofovir Disoproxil Fumarate/Emtricitabine and Elbasvir/Grazoprevir in Healthy Adult Participants
    Feng, Hwa-Ping
    Guo, Zifang
    Fandozzi, Christine
    Panebianco, Deborah
    Caro, Luzelena
    Wolford, Dennis
    Dreyer, Daniel R.
    Valesky, Robert
    Martinho, Monika
    Rizk, Matthew L.
    Iwamoto, Marian
    Yeh, Wendy W.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (07): : 952 - 961
  • [4] Bioequivalence of a paediatric fixed-dose combination tablet darunavir/cobicistat/emtricitabine/tenofovir alafenamide compared with coadministration of the separate agents in healthy adults
    Van Hemelryck, S.
    Van Landuyt, E.
    Ariyawansa, J.
    Vanveggel, S.
    Palmer, M.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 188 - 189
  • [5] Effects on vitamin D, bone and the kidney of switching from fixed-dose tenofovir disoproxil fumarate/emtricitabine/efavirenz to darunavir/ritonavir monotherapy: a randomized, controlled trial (MIDAS)
    Hamzah, Lisa
    Tiraboschi, Juan M.
    Iveson, Helen
    Toby, Martina
    Mant, Christine
    Cason, John
    Burling, Keith
    Wandolo, Emily
    Jendrulek, Isabelle
    Taylor, Chris
    Ibrahim, Fowzia
    Kulasegaram, Ranjababu
    Teague, Alastair
    Post, Frank A.
    Fox, Julie
    ANTIVIRAL THERAPY, 2016, 21 (04) : 287 - 296
  • [6] Tenofovir disoproxil fumarate, emtricitabine, and efavirenz versus fixed-dose zidovudine/lamivudine and efavirenz in anti retroviral-naive patients - Virologic, immunologic, and morphologic changes - A 96-week analysis
    Pozniak, Anton L.
    Gallant, Joel E.
    DeJesus, Edwin
    Arribas, Jose R.
    Gazzard, Brian
    Campo, Rael E.
    Chen, Shan-Shan
    McColl, Damian
    Enejosa, Jeffrey
    Toole, John J.
    Cheng, Andrew K.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 43 (05) : 535 - 540
  • [7] Development of HIV-1 Drug Resistance Through 144 Weeks in Antiretroviral-Naive Subjects on Emtricitabine, Tenofovir Disoproxil Fumarate, and Efavirenz Compared With Lamivudine/Zidovudine and Efavirenz in Study GS-01-934
    Margot, Nicolas A.
    Enejosa, Jeff
    Cheng, Andrew K.
    Miller, Michael D.
    McColl, Damian J.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 52 (02) : 209 - 221
  • [8] Bioequivalence of a Pediatric Fixed-Dose Combination Tablet Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Compared With Coadministration of the Separate Agents in Healthy Adults: An Open-Label, Randomized, Replicate Crossover Study
    Van Hemelryck, Sandy
    Van Landuyt, Erika
    Ariyawansa, Jay
    Vanveggel, Simon
    Palmer, Martyn
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2023, 12 (11): : 1060 - 1068
  • [9] Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic Study
    Neukam, Karin
    Espinosa, Nuria
    Collado, Antonio
    Delgado-Fernandez, Marcial
    Jimenez-Aguilar, Patricia
    Rivero-Juarez, Antonio
    Hontanon-Antonana, Victor
    Gomez-Berrocal, Ana
    Ruiz-Morales, Josefa
    Merino, Dolores
    Carrero, Ana
    Tellez, Francisco
    Jose Rios, Maria
    Hernandez-Quero, Jose
    de Lagarde-Sebastian, Maria
    Perez-Camacho, Ines
    Vera-Mendez, Francisco
    Macias, Juan
    Pineda, Juan A.
    PLOS ONE, 2016, 11 (05):
  • [10] A Randomized Crossover Study to Determine Relative Bioequivalence of Tenofovir, Emtricitabine, and Efavirenz (Atripla) Fixed-Dose Combination Tablet Compared With a Compounded Oral Liquid Formulation Derived From the Tablet
    King, Jennifer
    McCall, Matthew
    Cannella, Anthony
    Markiewicz, Michael Anne
    James, Amanda
    Hood, Chantelle B.
    Acosta, Edward P.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 56 (05) : E131 - E132
12